• 2 years ago
At today's Senate Judiciary Committee hearing, Sen. Adam Schiff (D-CA) questioned witnesses about PBM policies.
Transcript
00:00Thank you Mr. Chairman. Thank you for holding this hearing and thank you for
00:04the work you've done to try to reform the practices of PBMs. I have a long
00:11family history in this area. My grandfather was a pharmacist, my great
00:16uncle turns 100 this week, was a pharmacist. My father worked in a pharmacy
00:19growing up and of course I've had the same experience that so many of my
00:23constituents have had. Dr. Seude, thank you for coming all the way from
00:28California. Let me ask you about my experience because it's left me
00:35wondering what player in the scheme of things was responsible for my experience
00:40which was minor compared to what others have experienced and that is I was on a
00:44medication prescribed by my physician which was working very well without
00:47side-effect. Senator Schiff, when you're done will you adjourn the meeting? Yes I
00:52will. Thank you very much. And I may have to cut it short to to get out in time to
00:57vote. So I was on medicine that was worked with no side effects. I got a
01:01letter I think either from my insurer or PBM saying we're taking you off that
01:04medicine and putting you on a different one. And I called my physician I said why
01:09are we changing my medication was working perfectly. Well probably someone is going
01:16to get paid more money by moving you to something else. And I said well is there an
01:21appeal? And he said yeah but you'll lose. And I said well let's appeal anyway. So we
01:25appealed and he was right I lost. And then I said is there any other remedy
01:28decision? Well you can appeal one more time but you will lose again. We appeal one
01:31more time I lost again. So who made the decision to, well obviously it wasn't my
01:35physician, who made the decision that I was better off on a different medication?
01:40It was the PBM and I've had a similar experience where my university changed their
01:46PBM and there's a generic medicine you know FDA approved, been in the market for
01:5230 years, well established, suddenly wasn't covered because of the change in PBM.
01:59California experienced a 56 percent increase its Department of Managed
02:05Health Care in health plan spending on prescription drugs from 2017 to 2023. How
02:13much of that do you think is because of consolidation in the industry? Where
02:18would you apportion the increased costs? So I was one of the experts who you know
02:24back in 2017 opposed the CVS-Ethna merger on vertical grounds because I thought it
02:30would reduce competition in the pharmacy market, reduce competition in the
02:35insurance market, and lead to higher costs. I haven't seen the study but I agree
02:41with the general hypothesis that vertical integration could be responsible for
02:45higher costs. Well I wish I had more time to ask questions but I'm likely not
02:52to make it in time to vote without adjourning. Thank you all for your
02:56testimony today. This concludes our hearing. I want to thank each witness for
02:59taking the time to share your experience. Written questions can be submitted for
03:03the record until May 20th. I'll ask the witnesses to answer and return the
03:07questions the committee as quickly as possible. This hearing is adjourned.

Recommended